Management of recurrent and persistent metastatic lymph nodes in well‐differentiated thyroid cancer: A multifactorial decision‐making guide for the thyroid cancer care collaborative

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 37, Iss. 4, 2015-04 ,pp. : 605-614

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival

By  

JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, Vol. 59, Iss. 3, 2015-06 ,pp. : 281-288

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of nuclear medicine in differentiated thyroid cancer

By Kohlfürst Susanne  

Wiener Medizinische Wochenschrift, Vol. 162, Iss. 19-20, 2012-10 ,pp. : 407-415

Springer Publishing Company

Access to resources Recommend Favorite

The Evolving Use of Radioiodine Therapy in Differentiated Thyroid Cancer

By  

Oncology, Vol. 88, Iss. 4, 2014-12 ,pp. : 247-256

Karger

Access to resources Recommend Favorite

Scoring Patients’ Risk in Differentiated Thyroid Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 6, 2002-01 ,pp. : 561-568

Karger

Access to resources Recommend Favorite